Oncology & Cancer

Drug-light combo could offer control over CAR T-cell therapy

Bioengineers at the University of California San Diego are a step closer to making CAR T-cell therapy safer, more precise and easy to control. They developed a system that allows them to select where and when CAR T cells ...

Oncology & Cancer

Scientist designs 'express courier service' for immune cells

Immunotherapy is a promising cancer treatment that uses genetically modified immune cells to fight cancer. It can be used as a primary treatment or in combination with other treatments such as radiation and chemotherapy to ...

Oncology & Cancer

Super-powered immune cells

The phase 1 clinical trial will test the feasibility and safety of CAR-T cells—genetically modified white blood cells harvested from a patient's own blood with the unique ability to directly attack and kill cancers—to ...

Oncology & Cancer

New vaccine strategy boosts T-cell therapy

A promising new way to treat some types of cancer is to program the patient's own T cells to destroy the cancerous cells. This approach, termed CAR-T cell therapy, is now used to combat some types of leukemia, but so far ...

Oncology & Cancer

Confining cell-killing treatments to tumors

Cytokines, small proteins released by immune cells to communicate with each other, have for some time been investigated as a potential cancer treatment.

page 1 from 4